Related Experiment Video

Updated: Jul 3, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

Reduced interleukin-5 production by peripheral CD4+ T cells in common variable immunodeficiency patients

Giovanni Carlo Del Vecchio1, Baldassarre Martire, Giuseppe Lassandro

  • 1Department of Biomedicine of the Development Age, University of Bari, Bari, Italy.

Immunopharmacology and Immunotoxicology
|August 8, 2008
PubMed

Insights

Common Variable Immunodeficiency (CVI) patients show reduced interleukin-5 (IL-5) secretion from CD4+ T helper cells. This impaired IL-5 production may explain the defective antibody levels observed in CVI.

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Common Variable Immunodeficiency (CVI) is characterized by hypogammaglobulinemia and impaired antibody production.
  • CD4+ T helper cells play a crucial role in B cell differentiation and antibody secretion.

Purpose of the Study:

  • To investigate the interleukin-5 (IL-5) secretion capacity of peripheral CD4+ T helper cells in patients with CVI.
  • To explore the potential link between IL-5 deficiency and defective antibody production in CVI.

Main Methods:

  • Peripheral blood samples were collected from four CVI patients and healthy controls.
  • CD4+ T helper cells were stimulated and cultured in the presence of IL-2 or IL-15.
  • Interleukin-4 (IL-4) and IL-5 secretion levels were measured using ELISAs.

Main Results:

  • Control CD4+ T cells exhibited a significant 10-fold increase in IL-5 production upon stimulation.
  • In contrast, 3 out of 4 CVI patients demonstrated a markedly reduced, 4-fold increment in IL-5 secretion (p < 0.05).
  • IL-4 secretion levels were also assessed, though the primary finding focused on IL-5 reduction.

Conclusions:

  • A significant reduction in IL-5 secretion by CD4+ T helper cells is observed in most CVI patients.
  • Impaired IL-5 production, which regulates B cell differentiation into antibody-secreting plasma cells, may underlie the defective antibody production characteristic of CVI.

More Related Videos

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens06:03

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on: September 20, 2024

Development of an IFN-&#947; ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...